NMDPSM, a global nonprofit leader in cell therapy, and its collaborative research program, CIBMTR (Center for International ...

NMDPSM, a global nonprofit leader in cell therapy, and its collaborative research program, CIBMTR® (Center for ...

During a live event, Mojtaba Akhtari, MD, discussed trials studying patients with high-risk polycythemia vera.

Israel: A new study published in JAMA Network Open highlights a key safety insight for patients with type 2 diabetes taking ...

Q: I’m having some memory problems, and my doctor said to eat more salads. What does that have to do with anything? — Pat R., ...

Dr. Soma Mandal, a board-certified internist at Summit Health in New Providence, New Jersey, says that getting a CBC test is "recommended for individuals of all ages as part of a routine health ...

FLT3-ITD MRD dynamics predicted relapse risk and shaped response to gilteritinib maintenance in post-transplant AML.

Venous hematocrit is commonly used to inform blood volume status and assign risk to patients with heart failure; however, venous hematocrit only defines a percentage of red blood cells to total blood ...

Venous hematocrit (vHct) is commonly used to inform blood volume (BV) status and stratify cardiovascular risk. However, vHct defines a percentage of red blood cells (RBCs) to total BV; therefore, ...

We present a novel method for in-line acoustofluidic separation of cancer cells directly from whole blood. We report for the first time the observation that blood cells can self-organize when packed ...

Rusfertide, an investigational, first-in-class, self-injected peptide targeting the hepcidin pathway, shows efficacy in significantly reducing the need for phlebotomy in patients with polycythemia ...

This helps patients maintain a steady hematocrit level, which is the percentage of red blood cells in the body’s overall supply—a healthy level is at or below 45%.